By Frank Prenesti
Date: Monday 12 Jan 2026
(Sharecast News) - Life sciences investor RTW Biotech Opportunities said its private portfolio company Aktis Oncology had raised $318m via an IPO.
By Sharecast
Date: Friday 02 Jan 2026
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 2.20 |
| Change Today | $ -0.04 |
| % Change | -1.79 % |
| 52 Week High | $2.6 |
| 52 Week Low | $1.5 |
| Volume | 88,749 |
| Shares Issued | 321.14m |
| Market Cap | $706.51m |
| Beta | 0.00 |
| RiskGrade | 206 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 11:53 | 3,000 @ $2.20 |
| 11:49 | 540 @ $2.20 |
| 11:49 | 351 @ $2.20 |
| 11:49 | 779 @ $2.20 |
| 11:49 | 231 @ $2.19 |
| Chair | William (Bill) Simpson |
You are here: research